市場調查報告書
商品編碼
1467565
2024-2032 年按不孕原因、手術、服務、最終用戶和地區分類的生育服務市場報告Fertility Services Market Report by Cause of Infertility, Procedure, Service, End-User, and Region 2024-2032 |
IMARC Group年,全球生育服務市場規模達到 407 億美元。
生育服務是指為治療不孕症而提供的程序。不孕症的定義是無法懷孕或足月懷孕。在男性中,其表現為精子數量低或男性荷爾蒙失衡的結果。對女性來說,不孕是指下視丘和腦下垂體等腺體缺乏正常功能,這些腺體可以刺激大腦中的激素,觸發卵巢釋放卵子。生育治療包括增加懷孕機會的藥物和手術。它們涉及生育藥物、人工授精、體外受精(IVF)、卵子冷凍或卵母細胞冷凍保存、代孕、輔助生殖技術(ART)程序等。 他們協助不孕夫婦、單親父母和 LGBT 群體成員計劃生育計劃。家庭。
以職業為導向的人口基數不斷擴大,導致延遲懷孕現像日益普遍,這對市場成長做出了重大貢獻。由於擔心昂貴的托兒服務、學術或職業抱負以及缺乏經濟穩定性等問題,人們往往選擇晚生孩子,當他們更成熟和經濟狀況良好時。然而,過度的工作負荷和隨之而來的壓力,以及久坐的生活習慣,包括吸煙和吸毒,導致許多人出現不孕問題。此外,子宮內膜結核、多囊性卵巢症候群(PCOS)和可能導致不孕的性傳染病(STD)等各種醫療疾病的盛行率不斷上升,預計也將促進市場的成長。此外,個人意識的增強以及改善醫療設施的可近性進一步增加了已開發經濟體和新興經濟體對這些服務的採用。其他因素,例如電視和線上入口網站上生育服務廣告和促銷的增加,以及可支配收入的增加和健康保險公司提供的靈活保險範圍,也促進了市場的成長。
The global fertility services market size reached US$ 40.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 129.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.3% during 2024-2032.
Fertility services refer to the procedures provided as a treatment for infertility. Infertility is defined as the inability to conceive or carry a full-term pregnancy. Among males, it is identified by a low sperm count or is a result of hormonal imbalance in men. For females, infertility refers to the lack of proper functioning of glands such as hypothalamus and pituitary gland that stimulate hormones in the brain to trigger the ovaries to release an egg. Fertility treatments include medications and procedures that increase the chances of pregnancy. They involve fertility drugs, artificial insemination, In Vitro Fertilization (IVF), egg-freezing or oocyte cryopreservation, surrogacy, Assisted Reproductive Technology (ART) procedures, etc. They assist infertile couples, single parents and members of the LGBT community to plan a family.
The expanding career-oriented population base has led to the increasing prevalence of delayed pregnancies, which is contributing significantly to the market growth. Owing to concerns such as expensive childcare services, academic or career ambitions, and a lack of financial stability, people often opt to have children late in life when they are more mature and financially established. However, excessive workload and the accompanying stress along with sedentary lifestyle habits including smoking and consumption of drugs lead to infertility issues among many of them. Moreover, the rising prevalence of various medical ailments such as endometrial tuberculosis, polycystic ovarian syndrome (PCOS) and sexually transmitted diseases (STDs) that can cause infertility, is also projected to catalyze the growth of the market. Additionally, growing awareness among individuals and increasing accessibility to improved healthcare facilities have further increased the adoption of these services in both developed and emerging economies. Other factors such as increasing advertising and promotion of fertility services on televisions and online portals along with the rising disposable incomes and flexible coverage offered by health insurance companies are also augmenting the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global fertility services market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on cause of infertility, procedure, service, and end-user.
Male Infertility
Female Infertility
In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
Surrogacy
In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
Intrauterine Insemination (IUI)
Others
Fresh Non-Donor
Frozen Non-Donor
Egg and Embryo Banking
Fresh Donor
Frozen Donor
Fertility Clinics
Hospitals
Surgical Centres
Clinical Research Institutes
Cryobanks
Europe
North America
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Instituto Bernabeu Group, INVO Bioscience, Inc., Monash IVF Group, Apollo Hospitals Enterprise Ltd., CARE Fertility Group Ltd., Carolinas Fertility Institute, Genea Limited, The Cooper Companies, Inc., Virtus Health Group, Vitrolife Sweden AB, The Johns Hopkins Health System Corporation, Medicover AB (publ), OvaScience, Inc., Progyny, Inc., and Xytex Corporation.
IMARC Group's latest report provides a deep insight into the global fertility services market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the fertility services market in any manner.